Targiniq and Omeprazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Targiniq (naloxone hydrochloride; oxycodone hydrochloride) and Omeprazole (omeprazole). Common drug interactions include hypotension among females and femur fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Targiniq and Omeprazole. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Targiniq?

Targiniq has active ingredients of naloxone hydrochloride; oxycodone hydrochloride. eHealthMe is studying from 580 Targiniq users. Check the latest studies of Targiniq.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.



On Jul, 08, 2026

46 people who take Targiniq and Omeprazole together, and have interactions are studied.

Targiniq and Omeprazole drug interactions.

What are the common drug interactions of Targiniq and Omeprazole, by gender? *:

female:

  1. Hypotension (abnormally low blood pressure)
  2. Electrocardiogram qt prolonged
  3. Intentional self-injury
  4. Dyspnoea (difficult or laboured respiration)
  5. Abdominal pain upper
  6. Alopecia (absence of hair from areas of the body)
  7. Arthralgia (joint pain)
  8. C-reactive protein increased
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Erythema (redness of the skin)

male:

  1. Femur fracture
  2. Pyrexia (fever)
  3. Dizziness
  4. Temporomandibular joint syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress)
  5. Vision blurred
  6. Blood pressure increased
  7. Glaucoma (increased fluid pressure in the eye with vision loss)
  8. Hemiparesis (weakness on one side of the body)
  9. Iritis (painful inflammation of the iris of the eye)
  10. Necrotising panniculitis (inflammation of subcutaneous adipose tissue life threatening)

What are the common drug interactions of Targiniq and Omeprazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arthralgia (joint pain)
  2. C-reactive protein increased
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Erythema (redness of the skin)
  5. Heart rate increased
  6. Joint stiffness
  7. Lymphadenopathy (disease or enlargement of lymph nodes)
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Myalgia (muscle pain)
  10. Nasopharyngitis (inflammation of the nasopharynx)

30-39:

  1. Alopecia (absence of hair from areas of the body)
  2. Asthenia (weakness)
  3. Blood phosphorus decreased
  4. Fatigue (feeling of tiredness)
  5. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Pruritus (severe itching of the skin)

40-49:

  1. Femur fracture
  2. Pyrexia (fever)
  3. Device related infection
  4. Febrile neutropenia (fever with reduced white blood cells)
  5. Electrocardiogram qt prolonged
  6. Hypotension (abnormally low blood pressure)
  7. Intentional self-injury
  8. Peripheral embolism (sudden interruption of blood flow to an organ or body part)

50-59:

  1. Abdominal pain upper
  2. Electrocardiogram qt prolonged
  3. Hypotension (abnormally low blood pressure)
  4. Intentional self-injury
  5. Cerebral haemorrhage (bleeding within the brain)
  6. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  2. Hypotension (abnormally low blood pressure)
  3. Flushing (the warm, red condition of human skin)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypersensitivity
  6. Alopecia (absence of hair from areas of the body)
  7. Angina pectoris (chest pain due to ischemia of the heart muscle)
  8. Blood pressure increased
  9. Bradycardia (abnormally slow heart action)
  10. Cerebral haemorrhage (bleeding within the brain)

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 21.74%
  2. Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 9 people, 19.57%
  3. Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 19.57%
  4. Fever: 4 people, 8.70%
  5. Femur Fracture: 4 people, 8.70%
  6. Pain: 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Targiniq and Omeprazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Targiniq and Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Targiniq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Targiniq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride; oxycodone hydrochloride and omeprazole (the active ingredients of Targiniq and Omeprazole, respectively), and Targiniq and Omeprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: